Immunotherapy

Consult with Dr. Vikesh Shah MBBS, MD (AIIMS, New Delhi)

Online Schedule

bt_bb_section_bottom_section_coverage_image

Immunotherapy is a new technique of cancer treatment where the immune system of the body can detect, recognize, and kill the cancer cells. In contrast to the conventional way by chemotherapy and radiotherapy in both killing the normal and the cancer cells, immunotherapy is less painful and in most cases more accurate. With the advancement of biotechnology and the discovery of immunology, immunotherapy is changing the pattern of cancer treatment with hope that the rest is behind.

What Is Immunotherapy?

Immunotherapy, or biological therapy, is disease treatment that activates or boosts the body’s natural defense against disease—cancer being the exception. The immune system is a collection of cells, tissues, and organs that protect the body from infection and the development of tumor cells. It consists of white blood cells (such as T cells, B cells, macrophages, and dendritic cells) and organs such as the spleen, lymph nodes, and bone marrow.

Biologic drugs may include the application of natural substances within the body or lab-created copies. Cancer immunotherapy most typically occurs in the form of activation immunotherapies, whose goal is to test the immune system to be even tougher on cancer cells.

How Immunotherapy Works Against Cancer

The immune system, as part of its normal function, identifies and kills abnormal cells before they can harm. Tumors have developed mechanisms to evade detection. Cancer cells are able to:

  • Alter surface antigens so that they will not be identified by the immune system.

  • Trigger signals to discourage immune attacks.

  • Enlist normal cells in their vicinity to form a niche to kill immune attacks.

Immunotherapy fights such evasive mechanisms by restoring immune cells, for example, or eliminating blocking signals. Tumor-infiltrating lymphocytes (TILs) are immune cells within and beyond the tumor. They typically indicate that the immune system is trying to infiltrate the tumor, and their number typically is a good predictor of improved therapy outcome.

Types of Immunotherapy for Cancer

There are several cancer immunotherapies for various mechanisms and applications:

  1. Immune Checkpoint Inhibitors

These medications inhibit checkpoint proteins that prevent T cells from attacking cancer cells. Most commonly targeted are

  • PD-1/PD-L1 (Programmed death-1/ligand)
  • CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4)
    By inhibiting the checkpoints, immunotherapy checkpoint drugs reactivate T cell function and provide permission for a much more vigorous assault on cancer by the immune system. Used as a melanoma treatment and lung, bladder, kidney, and head and neck cancer treatment, these drugs are a huge leap ahead of cancer immunotherapy.
  1. T-cell Transfer Therapy (Adoptive Cell Therapy)

Using the patient’s own T cells, growing them in a laboratory, and re-infusing them into the body. Methods are

  • Tumor-infiltrating lymphocyte (TIL) therapy
  • CAR T-cell therapy (Chimeric Antigen Receptor)
    Gene editing is employed in T cells to get them to create cancer-specific antigen receptors through gene editing in CAR T-cell therapy. It is personalized to the patient, and positive results have been reported with the treatment, mainly for blood cancers like leukemia and lymphoma.
  1. Monoclonal Antibodies

These gene-engineered molecules are mimics of the natural antibodies and are designed to bind to certain antigens on cancer cells. Some of them are “flags” for cancer cells to be destroyed by immune cells. Some of them provide toxins or radioactive isotopes with a direct delivery within tumor tissue. Examples are

  • Trastuzumab (Herceptin) for breast cancer with HER2 overexpression
  • Rituximab (Rituxan) for lymphoma, non-Hodgkin’s type
  1. Cancer Treatment Vaccines

Therapeutic vaccines are used to activate the immune system to kill existing cancer. They are derived from:

  • Tumor-associated antigens
  • Patient-derived tumor cells
  • Genetic material like DNA or RNA
    An instance of an FDA-approved therapeutic cancer vaccine that has been used in the treatment of advanced prostate cancer is Sipuleucel-T (Provenge).
  1. Immune System Modulators

They are immunomodulatory drugs that can enhance the immune response more broadly or more specifically. Some examples are

  • Cytokines like interleukins (IL-2, IL-7, IL-12) and interferons
  • Chemokines, which attract immune cells to the tumor

Checkpoint agonists, which activate immune cells

Which Cancers Are Treated with Immunotherapy?

Immunotherapy is used or in development for the treatment of many different types of cancer, including:

  • Melanoma
  • Non-small cell lung cancer (NSCLC)
  • Renal cell carcinoma
  • Hodgkin lymphoma
  • Leukemic blast cells
  • Bladder cancer
  • Head and neck squamous cell carcinoma
  • Triple-negative breast cancer
  • Cervical and colorectal cancer
    New and emerging uses include pancreatic, ovarian, and brain cancer, as scientists create new combinations of immunotherapies and delivery systems.

How Is Immunotherapy Administered?

Immunotherapy is given in a variety of ways, depending on the type of treatment and type of cancer:

  • Intravenous (IV): Most typical type—delivered into a vein.
  • Oral: Given orally in capsule or tablet form.
  • Topical: Delivered directly onto the skin itself to treat skin cancers that are limited to the skin.
  • Intravesical: Given directly into the bladder to treat bladder cancer.

Where and How Often It Is Given

Immunotherapies are usually outpatient infusion therapy administered in hospitals, clinics, or doctor’s offices. Frequency and duration vary based on such factors as:

  • Stage and type of cancer
  • Type of immunotherapy
  • Patient response and side effect
    Treatment is cyclical or ongoing—treatment interrupted with rest periods.

Side Effects of Immunotherapy

Less well tolerated than chemotherapy, immunotherapy is seldom side effect free owing to its immune-enhancing nature. They are:

  • Fatigue
  • Fever and chills
  • Nausea
  • Inflammation of normally healthy organs (autoimmune flares) such as pneumonitis, colitis, hepatitis, or endocrinopathies
    Occasional side effects, but life-threatening and serious. Immediate treatment and close monitoring are necessary.

How Do You Know It’s Working?

Doctors measure how well treatment is going with

  • Imaging tests (CT, MRI, PET scans)
  • Lab tests (tumor markers, immune cells)
  • Physical examination and symptom evaluation
    It is slower than chemotherapy. There is some pseudo-progression in the patients’ tumor growth during the period of initial infiltration of the immune cells followed by normalization.

New Advances in Immunotherapy

  1. Resistance Overcoming

Immunotherapy will not succeed in all tumors. Scientists are attempting to combine

  • Checkpoints inhibitors with chemotherapy or radiotherapy
  • CAR-T therapy and immune modulators
  • Vaccines and T-cell therapies
  1. Response Prediction

PD-L1 expression biomarkers, MSI, and TMB decide who will be helped by immunotherapy.

  1. Minimizing Side Effects

Techniques are investigated to design targeted delivery platforms and combine therapies with immune-suppressive molecules to minimize autoimmune side effects selectively without sacrificing efficacy.

  1. Next-Generation Therapies

Cancer therapy progress is:

  • Neoantigen vaccines
  • Oncolytic viruses
  • Bispecific T-cell engagers (BiTEs)
  • Engineered dendritic cells

Gene editing in immune cells (e.g., CRISPR-Cas9)

Finding Immunotherapy Clinical Trials

Immunotherapy is guided by clinical trials. Clinical trials can be accessed with:

  • NCI’s Clinical Trials Database: cancer.gov/about-cancer/treatment/clinical-trials

  • ClinicalTrials.gov

  • By contacting the Cancer Information Service: 1-800-4-CANCER

Other uses of Immunotherapy

Allergen Immunotherapy

Otherwise referred to as desensitization, this type of immunotherapy exposes patients slowly to allergens such as pollen or food in an effort to decrease allergic reactions. It may include:

  • Subcutaneous injections

  • Sublingual tablets or drops

  • Oral immunotherapy (OIT) for food allergy such as peanuts
    Side effects are localized reactions and, in severe cases, anaphylaxis.

Autoimmune Disease Tolerance Therapy

Immunosuppression of autoimmune disease is also attained through immunotherapy to dampen immune response in autoimmune diseases such as:

  • Type 1 diabetes

  • Rheumatoid arthritis

  • Multiple sclerosis
    Treatment includes infusion with regulatory T cells, stem cell transplant, and tolerogenic vaccines.

Helminthic Therapy

Though still in experimental stages, helminths (parasitic worms) are also being explored for their immune-suppressive effects. Therapeutic effects have been reported in conditions such as Crohn’s and multiple sclerosis, possibly by modulation of cytokines and restoration of immune homeostasis.

The Future of Immunotherapy (2025 and Beyond)

Where is this going?

Let us look at some of the encouraging trends that are writing the next chapter of cancer immunotherapy:

🧠 Brain Tumor Immunotherapy

Glioblastoma is the most lethal cancer. New research is giving hope with viral vectors and CAR T-cells to cross the blood-brain barrier.

💥 Combination Therapies

Immunotherapy with:

  • Chemotherapy

  • Radiation

  • Targeted drugs

  • Other immunotherapies
    is giving better outcomes and fewer resistances.

🧪 Gene Editing with CRISPR

Researchers are now editing T-cells more precisely using CRISPR, so they kill more tumors and live longer in the body.

🛡️ Is Preventive Immunotherapy Coming?

Scientists are also performing preventive immunotherapy in those patients who are at a high risk — i.e., BRCA mutation carriers or Lynch syndrome patients.

Need the Best Immunotherapy Doctor in India?

If you or your loved one is looking to take immunotherapy in India, there is one name that stands head and shoulders above the rest — Dr. Vikesh Shah.

Trained through experience, empathy, and other forms of therapeutic methods, Dr. Vikesh Shah is now one of the most renowned and trusted immunotherapy physicians in the nation. Working from Ahmedabad, he has a dedicated clinic that specializes in giving cancer patients the best possible care that they deserve through innovative immunotherapy treatment.

Why patients put their trust in Dr. Vikesh Shah:

  • Years of clinical expertise in the use of checkpoint inhibitors, CAR T-cell therapy, and individualized immunotherapy protocols.

  • A universal approach — balancing cutting-edge medicine with patient-based care.

  • A source of information about the current clinical best practice and researches in cancer therapies.

🧭 You or your loved one are fighting cancer and searching for the best immunotherapy specialist in India?

Don’t wait — book an appointment with Dr. Vikesh Shah’s clinic in Ahmedabad. Hope, healing, and cutting-edge care await you.

💭 Last Thoughts: Why It Matters

Cancer touches us all — directly or indirectly. Immunotherapy is a medical miracle because it’s a philosophical change in the way we treat.

We’re moving from:

❌ “Kill the cancer no matter what”
to
✅ “Let the body do what it was made to do — defend and heal itself.”
It’s not science all the way. It’s hope, empowerment, and humankind at their finest.

📌 Key Takeaways 

✅ Immunotherapy is changing cancer therapy with the power of the immune system.
✅ It comprises checkpoint inhibitors, CAR T-cell treatment, cancer vaccines, and many more.
✅ 2025 is also seeing advances such as AI being integrated, off-the-shelf CAR T-cells, and mRNA shots.
✅ There are side effects but they are manageable.
✅ The world is still out of reach, but the breakthroughs are on our doorstep.
✅ Tomorrow is bright — and very much human.

🌅 A New Era

After everything we’ve had to fight through in order to make it to this new era of cancer treatment, immunotherapy is the bright smile of tomorrow. It’s not yet the fix for every cancer — but for many, it’s making the unthinkable possible.